Keyword: Genzyme

News

Sanofi Lets Genzyme's Biotech Culture Call the Shots

16.11.2012 - When Sanofi boss Chris Viehbacher first met staff at Genzyme, the U.S. biotech he had just acquired after a long takeover battle, he told them he did not want "planeloads of people...

News

Europe Approves High-Price Gene Therapy

02.11.2012 - European officials have approved the Western world's first gene therapy drug from a small Dutch biotech company, in a milestone for the novel medical technology that fixes faulty...

News

Sanofi Draws Fire Over Cost of MS Drug Lemtrada

01.11.2012 - Medical journal The Lancet warned that Sanofi's experimental multiple sclerosis drug Lemtrada may be too costly for patients and health insurers once it gets approved by regulators...

News

Sanofi Sees Relief from Patent Loss Pain

25.10.2012 - French drugmaker Sanofi forecast 2012 earnings would fall less than expected as cost cuts and demand for diabetes and rare disease drugs cushion the blow from patent expiries...

News

FDA Reviewers Spot Safety Concerns With Sanofi, Isis Lipid Drug

17.10.2012 - U.S. drug reviewers flagged several safety concerns, including possible cancer risks, related to Sanofi and Isis Pharmaceuticals's lipid disorder drug Kynamro, sending Isis's...

Plant Construction & Process Technology

Stick to Your Strengths with Biosimilars

25.09.2012 - Pharmaceuticals - Of the many challenges inherent with biosimilar development, the inability to predict market expectations may top the list for decision makers. While uncertainty...

News

Sanofi Strong in Emerging Markets as Rivals Flag

28.04.2012 - French drugmaker Sanofi posted better-than-expected quarterly results, bolstered by strong emerging markets, breaking with a trend of earnings misses by European rivals AstraZeneca...

News

Global Pharma to Pump Cash Into Russia

03.11.2011 - Viiv Healthcare, a GlaxoSmithKline and Pfizer joint venture, will start manufacturing HIV medicines in Russia in partnership with local drugmaker Binnopharm. Agreeing a local...